McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings ...

McKesson Corp (MCK) reports a 10% revenue increase and raises earnings guidance, despite challenges in the medical surgical ...

McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms

Q2 2026 Management View Brian Tyler, CEO, reported "strong second quarter results, which reflect sustained momentum in our ...

McKesson raises annual profit forecast on robust demand for specialty drugs

() -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology ...
Zacks Investment Research on MSNOpinion

4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks

The Zacks Medical - Dental Supplies industry in the Medical sector is entering the final quarter of 2025 with strong momentum ...

Medline Files For IPO On Growth, But Heavy Debt Weighs

Medline Inc. eyes a $5B IPO to reduce debt amid strong growth in the medical disposables market. Click here to read my latest ...

What to Expect From McKesson's Next Quarterly Earnings Report

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the ...